Monitoring Symptoms to Help Young Women Take Hormone Therapy for Stage I-III Breast Cancer, ASPEN Study |
Best Practice, Biospecimen Collection, Endocrine Drug Therapy, Health Education, Questionnaire Administration, Symptom Specific Assessment Tool |
Recruiting |
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring |
Recruiting |
Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses |
Educational Intervention, Patient Navigation, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
A Study of miRNA 371 in Patients With Germ Cell Tumors |
Biomarker Analysis, Blood Product Collection |
Recruiting |
Does the Use of a Genomic Tumor Board Increase the Number of Patients Who Receive Genome-Informed Treatment |
Best Practice, Chart Abstraction, Educational Intervention, Genomic Profile, Interview, Questionnaire Administration, Tumor Board Review |
Recruiting |
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer |
Carvedilol, Laboratory Biomarker Analysis, Patient Observation |
Recruiting |
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy |
Biospecimen Collection, Cryocompression Therapy, Pneumatic Compression Therapy, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes |
Fasting Mimicking Diet (FMD), Standard Anti-Cancer Diet |
Recruiting |
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer |
Bio-Specimen Collection |
Recruiting |
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer |
Dasatinib plus Quercetin, Fisetin |
Recruiting |